OLANZAPINE /2.5 mg & 5 mg & 10 mg & 20 mg Tablet

Oroheks % 02 oral sprey belongs to the respiratory system category It is used for antiseptic Form: oral sprey Active substances: 02% chlorhexidine gluconate Package type: 30 ml glass bottle with oral applicator Licensor: tripharma

Oroheks %02 gargle 200 ml belongs to the respiratory system category It is used for antiseptic Form: gargle Active substances: 02% chlorhexidine gluconate Package type: 200 ml glass bottle; 15 ml measurement cap Licensor: abdi ibrahim ilaç

Oroheks plus oral sprey belongs to the respiratory system category It is used for antiinflammatory, antiseptic Form: oral sprey Active substances: 0,15 % benzydamine hcl, 0,12 % klorhexidine gluconate Package type: 30 ml glass bottle with oral applicator Licensor: tripharma

Osteomax tablet 70 mg belongs to the endocrine and metabolism category It is used for bone calcium regulators Form: tablets Active substances: alendronate sodium 9135 mg/ tablet Package type: alu/alu blister packs of 4 tablets Licensor: abdi ibrahim ilaç

Non-Steroidal Antirheumatics

Platelet aggregation inhibitors (COX inhibitors)

Adrenergics (B2 agonists) in combination with corticosteroids - Asthma & COPD

Thyroid Preparations - Hypothyroidism

Antiepileptic

NSAID

PDE5 Inhibitors - Erectile dysfunction

Selective serotonin reuptake inhibitors - Antidepressants

Abdi İbrahim has been awarded the 'Equal Opportunity Model' (FEM) certificate, developed by KAGIDER with the technical support of the World Bank, to promote gender equality in business life and enhance women's productivity. Deniz Daver, President of Human and Culture Group, expressed their happiness in receiving this certificate, stating, “This certificate, which acknowledges companies' sensitive approaches to gender equality and women's empowerment in employment, is an important indicator reflecting Abdi İbrahim's vision of inclusiveness. We see FEM certificate as a reward for our determined and continuous efforts in this field.

Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees.